Moderna to Report Q3 Results: Revenue Decline and Widening Losses Expected
MRNA Moderna Inc
$250.83 -6.75%
View chart & analysis → - 1The market expects Moderna's third-quarter revenue to be approximately $888.8 million with a loss of $1.10 per share.
- 2This represents a 12.5% decrease in revenue compared to Moderna's revenue of $1.02 billion one year ago.
- 3Management maintains its previous guidance of up to 10% annual revenue growth.
So what's the key point?
Moderna's third-quarter revenue is expected to decrease by 12.5% compared to last year. Experts anticipate the company will incur more losses rather than making a profit.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.